financetom
Business
financetom
/
Business
/
MacroGenics Signs Deal With TerSera Therapeutics for Sale of Margenza
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MacroGenics Signs Deal With TerSera Therapeutics for Sale of Margenza
Oct 22, 2024 12:20 PM

09:39 AM EDT, 10/22/2024 (MT Newswires) -- MacroGenics ( MGNX ) and TerSera Therapeutics said Tuesday they have signed an agreement under which TerSera will buy global rights to breast cancer drug Margenza.

Under the deal, TerSera will pay MacroGenics ( MGNX ) $40 million at closing, the companies said, adding MacroGenics ( MGNX ) may get sales milestone payments of up to $35 million.

The deal is expected to close in Q4.

Price: 3.88, Change: +0.02, Percent Change: +0.39

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved